Manuel Fankhauser

Manuel Fankhauser is a distinguished leader in the field of biotechnology and bioengineering, currently serving as the Chief Executive Officer of Seerave Foundation since January 2017, where efforts focus on enhancing the lives of cancer patients through innovative research and collaboration. In addition to this role, Fankhauser is the Chief Scientific Officer at Arven Partners LLC and a Co-Founder and Managing Partner at Nanolive SA. Fankhauser's extensive board involvement includes positions with Microbiota Vault and advisory roles with the Swiss Economic Forum and the Innovation Forum Lausanne. Notable past positions include Scientific Consultant for Cygnal Therapeutics and various academic roles at the Swiss Federal Institute of Technology (EPFL). Fankhauser holds a PhD in Biotechnology and Bioengineering from EPFL, an MSc in Biomedical Sciences from the University of Amsterdam, and a BSc in Biomedical Sciences from Université de Fribourg.